PROBLEM TO BE SOLVED: To provide a gelatinous oral preparation having improved swallowability of an HMG-CoA reductase inhibitor, so-called statin compound, administered to the patient of hyperlipemia or hypercholesterolemia at the care site in the form of tablet, granule or liquid.SOLUTION: The gelatinous drug composition free from disagreeable taste of statin compound, causing little syneresis in storage, having good shape retainability, easily takable from a container and having improved swallowability is composed of an HMG-CoA reductase inhibitor or its pharmacologically permissible salt, a gelatinizing agent, a polymeric compound, a buffering agent, a preservative, a sweetener, a base agent and water.COPYRIGHT: (C)2007,JPO&INPIT【課題】医療現場において、錠剤、顆粒及び液剤の剤形で高脂血症及び高コレステロール患者に投与されているHMG-CoA還元酵素阻害剤、所謂スタチン系化合物の服用性を向上させたゲル状の経口製剤の提供。【解決手段】HMG-CoA還元酵素阻害剤又は製薬学的に許容される塩、ゲル化剤、高分子化合物、緩衝剤、保存剤、甘味剤、基剤及び水からなり、スタチン系化合物の不快な味を感じさせず、保存時の離漿が少なく、保型性が良好で容器から取り出しやすく、服用性を向上させたことを特徴とするゲル状の医薬組成物。【選択図】 なし
